ArticleExperimental hematology & oncology2026

Long-term survival benefit of neoadjuvant oncolytic virus plus PD-1 blockade in acral melanoma: implications of STING in resistance and potential therapy.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.